Disorders of heavy metals

Handbook of Clinical Neurology

Volumn 120, Issue , 2014, Pages 851-864

  Woimant, France ^a   Trocello, Jean Marc ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Aceruloplasminemia; Copper; Heavy metals; Iron; Menkes disease; NBIA; Neuroferritinopathy; Occipital horn syndrome; PKAN; Wilson disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE; COPPER; HEAVY METAL; IRON;

ACERULOPLASMINEMIA; ARTICLE; GENETICS; HEAVY METALS; HUMAN; MENKES SYNDROME; METABOLIC DISORDER; METABOLISM; NBIA; NEUROFERRITINOPATHY; NEUROIMAGING; NEUROLOGIC DISEASE; OCCIPITAL HORN SYNDROME; PKAN; WILSON DISEASE;

ACERULOPLASMINEMIA; COPPER; HEAVY METALS; IRON; MENKES DISEASE; NBIA; NEUROFERRITINOPATHY; OCCIPITAL HORN SYNDROME; PKAN; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; HUMANS; METABOLIC DISEASES; METALS, HEAVY; NERVOUS SYSTEM DISEASES; NEUROIMAGING;

EID: 84890827320     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4087-0.00057-7     Document Type: Chapter

References (100)

1. Aicardi J., Castelein P. Infantile neuroaxonal dystrophy. Brain 1979, 102:727-748.
2. Ala A., Walker A.P., Ashkan K., et al. Wilson's disease. Lancet 2007, 369:397-408.
3. Allen R.P., Earley C.J. Restless legs syndrome. A review of clinical and pathophysiologic features. J Clin Neurophysiol 2001, 18:128-147.
4. Angelini L., Nardocci N., Rumi V., et al. Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life. J Neurol 1992, 239:417-425.
5. Barnes N., Tsivkovskii R., Tsivkovskaia N., et al. The copper-transporting ATPases, Menkes and Wilson disease proteins, have distinct roles in adult and developing cerebellum. J Biol Chem 2005, 280:9640-9645.
6. Benarroch E.E. Brain iron homeostasis and neurodegenerative disease. Neurology 2009, 72:1436-1440.
7. Beyersdorff A., Findeisen A. Morbus Wilson: case report of a two-year-old child as first manifestation. Scand J Gastroenterol 2006, 41:496-497.
8. Bremner I. Manifestations of copper excess. Am J Clin Nutr 1998, 67:1069S-1073S.
9. Brewer G.J., Askari F., Lorincz M.T., et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 2006, 63:521-527.
10. Brodkin E., Copes R., Mattman A., et al. Lead and mercury exposures: interpretation and action. CMAJ 2007, 176:59-63.
11. Bull P.C., Thomas G.R., Rommens J.M., et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993, 5:327-337.
12. Chappuis P., Bost M., Misrahi M., et al. Wilson disease: clinical and biological aspects. Ann Biol Clin (Paris) 2005, 63:457-466.
13. Chelly J., Tümer Z., Tønnesen T., et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet 1993, 3:14-19.
14. Ching K.H., Westaway S.K., Gitschier J., et al. HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration. Neurology 2002, 58:1673-1674.
15. Chinnery P.F., Crompton D.E., Birchall D., et al. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 2007, 130:110-119.
16. Connor J.R., Boyer P.J., Menzies S.L., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003, 61:304-309.
17. Cumings J.N. The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain 1948, 71:410-415.
18. Curtis A.R., Fey C., Morris C.M., et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001, 28:350-354.
19. Członkowska A., Rodo M., Gromadzka G. Late onset Wilson's disease: therapeutic implications. Mov Disord 2008, 23:896-898.
20. Danks D.M., Campbell P.E., Stevens B.J., et al. Menkes's kinky hair syndrome. An inherited defect in copper absorption with widespread effects. Pediatrics 1972, 50:188-201.
21. de Bie P., Muller P., Wijmenga C., et al. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet 2007, 44:673-688.
22. El Balkhi S., Trocello J.M., Poupon J., et al. Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson's disease diagnosis. Clin Chim Acta 2011, 412:2254-2260.
23. Favrole P., Chabriat H., Guichard J.P., et al. Clinical correlates of cerebral water diffusion in Wilson disease. Neurology 2006, 66:384-389.
24. Ferenci P., Steindl-Munda P., Vogel W., et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease. Clin Gastroenterol Hepatol 2005, 3:811-818.
25. Figus A., Angius A., Loudianos G., et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet 1995, 57:1318-1324.
26. Foruny J.R., Boixeda D., López-Sanroman A., et al. Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease. Scand J Gastroenterol 2008, 43:597-603.
27. Frydman M., Bonne-Tamir B., Farrer L., et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci U S A 1985, 82:1819-1821.
28. Grabli D., Auré K., Roze E. Movement disorders and neurometabolic diseases. Rev Neurol (Paris) 2011, 167:123-134.
29. Gregory A., Hayflick S.J. Pantothenate kinase-associated neurodegeneration. GeneReviews 1993-2002 [updated 2010], University of Washington, Seattle, [Internet]. R.A. Pagon, T.C. Bird, C.R. Dolan (Eds.).
30. Gregory A., Westaway S.K., Holm I.E., et al. Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology 2008, 71:1402-1409.
31. Gregory A., Polster B.J., Hayflick S.J. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet 2009, 46:73-80.
32. Hallervorden J., Spatz H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteilgung des Globus pallidus und der Substantia nigra: ein Beitrag zu den Beziehungen zwischen diesen beiden Zentren. Z Ges Neurol Psychiat 1922, 79:254-302.
33. Harrison P.M., Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996, 1275:161-203.
34. Hayflick S.J., Westaway S.K., Levinson B., et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003, 348:33-40.
35. Haywood S., Muller T., Muller W., et al. Copper-associated liver disease in North Ronaldsay sheep: a possible animal model for non Wilsonian hepatic copper toxicosis of infancy and childhood. J Pathol 2001, 195:264-269.
36. Hermann W., Guenther P., Clark D., et al. Polyneuropathy in idiopathic haemochromatosis. J Neurol 2002, 249:1316-1317.
37. Hoogenraad T. Wilson's Disease 2001, Internal Medical Pubishers, Amsterdam.
38. Horn N., Tønnesen T., Tümer Z. Menkes disease: an X-linked neurological disorder of the copper metabolism. Brain Pathol 1992, 2:351-362.
39. Ingster-Moati I., Bui Quoc E., Pless M., et al. Ocular motility and Wilson's disease: a study on 34 patients. J Neurol Neurosurg Psychiatry 2007, 78:1199-1201.
40. Jaiser S.R., Winston G.P. Copper deficiency myelopathy. J Neurol 2010, 257:869-881.
41. Jog M.S., Lang A.E. Chronic acquired hepatocerebral degeneration: case reports and new insights. Mov Disord 1995, 10:714-722.
42. Johnson M.A., Kuo Y.M., Westaway S.K., et al. Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration. Ann N Y Acad Sci 2004, 1012:282-298.
43. Kaler S.G. ATP7A-related copper transport disorders. GeneReviews 1993-2003 [updated 2010], University of Washington, Seattle, [Internet]. R.A. Pagon, T.C. Bird, C.R. Dolan (Eds.).
44. Kaler S.G. Metabolic and molecular bases of Menkes disease and occipital horn syndrome. Pediatr Dev Pathol 1998, 1:85-98.
45. Kennerson M.L., Nicholson G.A., Kaler S.G., et al. Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am J Hum Genet 2010, 86:343-352.
46. Kumar N. Superficial siderosis: associations and therapeutic implications. Arch Neurol 2007, 64:491-496.
47. Kurian M.A., Morgan N.V., MacPherson L., et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 2008, 70:1623-1629.
48. Letzel S., Lang C.J., Schaller K.H., et al. Longitudinal study of neurotoxicity with occupational exposure to aluminum dust. Neurology 2000, 54:997-1000.
49. Lorincz M.T. Neurologic Wilson's disease. Ann N Y Acad Sci 2010, 1184:173-187.
50. Lutsenko S., Barnes N.L., Bartee M.Y., et al. Function and regulation of human copper-transporting ATPases. Physiol Rev 2007, 87:1011-1046.
51. Madsen E., Gitlin J.D. Copper deficiency. Curr Opin Gastroenterol 2007, 23:187-192.
52. McNeill A., Pandolfo M., Kuhn J., et al. The neurological presentation of ceruloplasmin gene mutations. Eur Neurol 2008, 60:200-205.
53. McNeill A., Birchall D., Hayflick S.J., et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008, 70:1614-1619.
54. Medici V., Mirante V.G., Fassati L.R., et al. Monotematica AISF 2000 OLT study group. Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders. Liver Transpl 2005, 11:1056-1063.
55. Menkes J.H., Alter M., Steigleder G.K., et al. A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics 1962, 29:764-779.
56. Mercer J.F., Livingston J., Hall B., et al. Isolation of a partial candidate gene of Menkes disease by positional cloning. Nat Genet 1993, 3:20-25.
57. Merle U., Schaefer M., Ferenci P., et al. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007, 56:115-120.
58. Mikol J., Vital C., Wassef M., et al. Extensive cortico-subcortical lesions in Wilson's disease: clinico-pathological study of two cases. Acta Neuropathol 2005, 110:451-458.
59. Mills E., Dong X.P., Wang F., et al. Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Future Med Chem 2010, 2:51.
60. Miyajima H. Aceruloplasminemia, an iron metabolic disorder. Neuropathology 2003, 23:345-350.
61. Miyajima H., Nishimura Y., Mizoguchi K., et al. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987, 37:761-767.
62. Møller L.B., Mogensen M., Horn N. Molecular diagnosis of Menkes disease: genotype-phenotype correlation. Biochimie 2009, 91:1273-1277.
63. Moos T., Morgan E.H. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci 2004, 1012:14-26.
64. Nations S.P., Boyer P.J., Love L.A., et al. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 2008, 71:639-643.
65. Ory-Magne F., Brefel-Courbon C., Payoux P., et al. Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC). Mov Disord 2009, 24:1676-1683.
66. Peltonen L., Kuivaniemi H., Palotie A., et al. Alterations in copper and collagen metabolism in the Menkes syndrome and a new subtype of the Ehlers-Danlos syndrome. Biochemistry 1983, 22:6156-6163.
67. Pfeiffer R.F. Wilson's disease. Semin Neurol 2007, 27:123-132.
68. Roberts E.A., Schilsky M.L. American association for study of liver diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008, 47:2089-2111.
69. Russo N., Edwards M., Andrews T., et al. Hereditary haemochromatosis is unlikely to cause movement disorders - a critical review. J Neurol 2004, 251:849-852.
70. Sener R.N. Diffusion MR imaging changes associated with Wilson disease. AJNR Am J Neuroradiol 2003, 24:965-967.
71. Sethi P.K., Khandelwal D. Cadmium exposure: health hazards of silver cottage industry in developing countries. J Med Toxicol 2006, 2:14-15.
72. Shanmugiah A., Sinha S., Taly A.B., et al. Psychiatric manifestations in Wilson's disease: a cross-sectional analysis. J Neuropsychiatry Clin Neurosci 2008, 20:81-85.
73. Shaughnessy P., Lee J., O'Keeffe S.T. Restless legs syndrome in patients with hereditary hemochromatosis. Neurology 2005, 64:2158.
74. Smith M.A., Zhu X., Tabaton M., et al. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis 2010, 19:363-372.
75. Steindl P., Ferenci P., Dienes H.P., et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997, 113:212-218.
76. Stepens A., Logina I., Liguts V., et al. Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008, 358:1009-1017.
77. Suvarna J.C. Kayser-Fleischer ring. J Postgrad Med 2008, 54:238-240.
78. Tanzi R.E., Petrukhin K., Chernov I., et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993, 5:344-350.
79. Thomas G.R., Roberts E.A., Walshe J.M., et al. Haplotypes and mutations in Wilson disease. Am J Hum Genet 1995, 56:1315-1319.
80. Trocello J.M., Woimant F. Case study 3. Parkinsonian disorders in clinical practice 2008, 74-78. Wiley-Blackwell, Oxford. A. Schapira, A. Hartmann, Y. Agid (Eds.).
81. Trocello J.M., Chappuis P., Chaine P., et al. Wilson disease. Presse Med 2009, 38:1089-1098.
82. Trocello J.M., Chappuis P., El Balkhi S., et al. Abnormal copper metabolism in adult. Rev Med Interne 2010, 31:750-756.
83. Trocello J.M., Guichard J.P., Leyendecker A., et al. Corpus callosum abnormalities in Wilson's disease. J Neurol Neurosurg Psychiatry 2010, 82:1119-1121.
84. Trocello J.M., Hinfray S., Sanda N., et al. An unrecognized cause of myelopathy associated with copper deficiency: the use of denture cream. Rev Neurol (Paris) 2011, 167:537-540.
85. Tümer Z., Møller L.B. Menkes disease. Eur J Hum Genet 2010, 18:511-518.
86. Twomey P.J., Viljoen A., Reynolds T.M., et al. Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories. J Trace Elem Med Biol 2008, 22:50-53.
87. Valentine J.S., Gralla E.B. Delivering copper inside yeast and human cells. Science 1997, 278:817-818.
88. van Wassenaer-van Hall H.N., van den Heuvel A.G., Algra A., et al. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996, 198:531-536.
89. Vernooij M.W., Ikram M.A., Hofman A., et al. Superficial siderosis in the general population. Neurology 2009, 73:202-205.
90. Vulpe C., Levinson B., Whitney S., et al. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet 1993, 3:7-13.
91. Walshe J.M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med 1956, 21:487-495.
92. Walshe J.M. History of Wilson's disease: 1912 to 2000. Mov Disord 2006, 21:142-147.
93. Walshe J.M., Waldenström E., Sams V., et al. Abdominal malignancies in patients with Wilson's disease. QJM 2003, 96:657-662.
94. Wiggelinkhuizen M., Tilanus M.E., Bollen C.W., et al. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009, 29:947-958.
95. Wilson S.A.K. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912, 34:295-507.
96. Woimant F., Chaine P., Favrole P., et al. Wilson disease. Rev Neurol (Paris) 2006, 162:773-781.
97. Yamaguchi Y., Heiny M.E., Gitlin J.D. Isolation and characterization oh a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993, 197:271-277.
98. Yong R.L., Holmes D.T., Sreenivasan G.M. Aluminum toxicity due to intravenous injection of boiled methadone. N Engl J Med 2006, 354:1210-1211.
99. Yoon S.J., Koh Y.H., Floyd R.A., et al. Copper, zinc superoxide dismutase enhances DNA damage and mutagenicity induced by cysteine/iron. Mutat Res 2000, 448:97-104.
100. Zhou B., Westaway S.K., Levinson B., et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001, 28:345-349.